CILP

cartilage intermediate layer protein, the group of Immunoglobulin like domain containing

Basic information

Region (hg38): 15:65194760-65211473

Links

ENSG00000138615NCBI:8483OMIM:603489HGNC:1980Uniprot:O75339AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CILP gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CILP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
1
clinvar
7
missense
89
clinvar
2
clinvar
6
clinvar
97
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 90 8 7

Variants in CILP

This is a list of pathogenic ClinVar variants found in the CILP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-65196790-C-T CILP-related disorder Benign (Oct 16, 2019)3060299
15-65196835-G-T not specified Uncertain significance (Dec 13, 2021)2266602
15-65196910-G-A not specified Uncertain significance (Apr 05, 2023)2533327
15-65196919-G-C not specified Uncertain significance (Feb 13, 2024)3145026
15-65196945-G-C not specified Uncertain significance (Sep 01, 2021)2248262
15-65196948-A-G Uncertain significance (-)1049471
15-65197052-A-G CILP-related disorder Likely benign (May 24, 2019)3038907
15-65197062-C-T not specified Uncertain significance (May 31, 2023)2517564
15-65197096-G-A Benign (Aug 03, 2017)785496
15-65197117-C-T not specified Uncertain significance (Nov 21, 2022)2328844
15-65197185-C-T not specified Likely benign (Aug 22, 2023)2592006
15-65197186-G-A not specified Uncertain significance (Jan 08, 2024)3145025
15-65197231-G-A not specified Uncertain significance (Dec 02, 2022)2408528
15-65197231-G-C not specified Uncertain significance (Mar 04, 2024)3145024
15-65197251-C-T not specified Uncertain significance (May 26, 2024)3267369
15-65197278-G-T not specified Uncertain significance (Jun 22, 2023)2603840
15-65197305-C-T not specified Uncertain significance (Nov 18, 2022)2327422
15-65197306-G-A not specified Uncertain significance (Dec 04, 2023)3145023
15-65197345-C-T not specified Uncertain significance (Jul 17, 2023)2612272
15-65197350-T-C CILP-related disorder Benign (Jan 02, 2020)3058903
15-65197367-C-T not specified Uncertain significance (May 27, 2022)2399310
15-65197479-C-T not specified Uncertain significance (Feb 06, 2023)2456324
15-65197527-T-C Uncertain significance (-)1049475
15-65197588-G-A not specified Uncertain significance (Mar 06, 2023)2458850
15-65197693-C-T not specified Uncertain significance (Jan 31, 2024)3145022

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CILPprotein_codingprotein_codingENST00000261883 815490
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.37e-260.00032312549232531257480.00102
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1706937060.9820.00004187772
Missense in Polyphen332339.520.977863706
Synonymous0.5732582700.9560.00001472404
Loss of Function0.06263939.40.9890.00000215451

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002560.00255
Ashkenazi Jewish0.0001980.000198
East Asian0.001910.00180
Finnish0.0003720.000370
European (Non-Finnish)0.0007950.000783
Middle Eastern0.001910.00180
South Asian0.001840.00170
Other0.002130.00212

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probably plays a role in cartilage scaffolding. May act by antagonizing TGF-beta1 (TGFB1) and IGF1 functions. Has the ability to suppress IGF1-induced proliferation and sulfated proteoglycan synthesis, and inhibits ligand-induced IGF1R autophosphorylation. May inhibit TGFB1-mediated induction of cartilage matrix genes via its interaction with TGFB1. Overexpression may lead to impair chondrocyte growth and matrix repair and indirectly promote inorganic pyrophosphate (PPi) supersaturation in aging and osteoarthritis cartilage. {ECO:0000269|PubMed:12746903, ECO:0000269|PubMed:15864306}.;
Disease
DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:15864306}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. {ECO:0000269|PubMed:15864306}.;
Pathway
Signal Transduction;Signaling by Receptor Tyrosine Kinases;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) (Consensus)

Recessive Scores

pRec
0.139

Intolerance Scores

loftool
0.980
rvis_EVS
-1.53
rvis_percentile_EVS
3.34

Haploinsufficiency Scores

pHI
0.251
hipred
N
hipred_score
0.216
ghis
0.529

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.376

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyHighMediumHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Cilp
Phenotype

Gene ontology

Biological process
negative regulation of gene expression;dephosphorylation;negative regulation of insulin-like growth factor receptor signaling pathway;negative regulation of SMAD protein signal transduction;cellular response to transforming growth factor beta stimulus
Cellular component
extracellular space;collagen-containing extracellular matrix;extracellular exosome
Molecular function
alkaline phosphatase activity;nucleotide diphosphatase activity;extracellular matrix structural constituent